🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)5mg → 10mg → 15mg titration — March 2026 Page 2

5mg → 10mg → 15mg titration — March 2026

BiostatsBrad Wed, Jun 4, 2025 at 8:46 PM 49 replies 2,557 viewsPage 2 of 10
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Jun 5, 2025 at 1:54 AM#6
VendorMark said:
A step that is uncomfortable at week two is frequently comfortable at week six with no change in dose, because the gastric-emptying component…

I disagree that the ladder is purely tolerability. The maintenance and regain data cluster at the top doses, so a ladder abandoned halfway leaves you outside the evidence base for the part that matters most — keeping it off.

15 18SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 12 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Jun 5, 2025 at 3:55 AM#7
BiostatsBrad said:
Four dose steps in, holding each one the full four weeks, and I am trying to work out whether the interval is a pharmacological requirement or a…

Dose escalation anxiety for titration: I was terrified to move from 0.5mg to 1.0mg based on horror stories in this forum. But my actual experience? Slightly more appetite suppression, zero additional side effects.

Remember that the people posting about terrible side effects are a biased sample. Most people titrate up without drama — they just don't post about it because it's uneventful.

16 19Dr.DermMIA, fiona_VT, denise_HTX and 13 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Jun 5, 2025 at 5:56 AM#8
Dr.MetabolicMD said:
I disagree that the ladder is purely tolerability.

Coming at Dr.MetabolicMD’s question from a different direction. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

17 20Dr.Martinez, mike_mod, SarahChen_PharmD and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Jun 5, 2025 at 7:57 AM#9

Following on from nancy_portland — and this may be the naive question:

Why the interval is four weeks rather than two, and whether a slower ladder gets to the same place?

18 21PharmHunterJen, TomTeleRx, DoseLogDan and 15 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jun 5, 2025 at 5:36 PM#10

Closing the loop on my own question.

Update — I came back down one step, held for a month, then went up again and it was uneventful the second time. Same ladder, slower.

Last edited: Jun 5, 2025 at 6:36 PM
4 4NicoleRaleigh, james_edin, FranDenver and 1 other
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register